Viewing Study NCT02110394


Ignite Creation Date: 2025-12-25 @ 1:40 AM
Ignite Modification Date: 2026-03-01 @ 1:49 AM
Study NCT ID: NCT02110394
Status: COMPLETED
Last Update Posted: 2016-07-06
First Post: 2014-04-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Ribomustin in the First Line Therapy of Chronic Lymphocytic Leukemia
Sponsor:
Organization: